[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BioStocks Avatar @BioStocks Bio Stocks™

Bio Stocks™ posts on X about bio, $rzlt, $wve, $xbi the most. They currently have XXXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.

Engagements: XXXXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXXX #

Followers Line Chart

CreatorRank: XXXXXXX #

CreatorRank Line Chart

Social Influence

Social category influence finance XXXXX% stocks XXXX% cryptocurrencies XXXX% vc firms #283 currencies XXXX% technology brands XXXX%

Social topic influence bio #1185, $rzlt #26, $wve #16, $xbi #15, $lly #52, $rytm 3.13%, $350m #7, $tern #1, $aciu #7, $nvo #64

Top accounts mentioned or mentioned by @mbrushstocks @biotechtoast @biopharmiq @fwcweather @tradingsssss @markettargetz @biopharma_watch @rnaianalyst @samfazeli8 @zipjet @truedat999 @biotech2k1 @jul05310473john @polycle @tim925256475865 @semodough @learnbiotech @m56804962 @pgainz96934 @jcannush

Top assets mentioned Wave Life Sciences Ltd. Ordinary Shares (WVE) Bitcoin Incognito (XBI) Eli Lilly and Company (LLY) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Terns Pharmaceuticals, Inc. Common Stock (TERN) Novo-Nordisk (NVO) Kymera Therapeutics, Inc. Common Stock (KYMR) Ocular Therapeutix, Inc. (OCUL) Dyne Therapeutics, Inc. Common Stock (DYN) Hims & Hers Health, Inc. (HIMS) Alkermes Inc. plc (ALKS) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Taraxa (TARA) Janux Therapeutics, Inc. Common Stock (JANX) Corcept Therapeutics Inc. (CORT) Dawn Protocol (DAWN) Sarepta Therapeutics, Inc. (SRPT) Viking Therapeutics, Inc (VKTX) BridgeBio Pharma, Inc. Common Stock (BBIO) Biogen Inc (BIIB) Natera, Inc. Common Stock (NTRA) Insmed, Inc. (INSM) Teva Pharmaceutical Industries Limited American Depositary Shares (TEVA) Ionis Pharmaceuticals, Inc. Common Stock (IONS) AstraZeneca PLC (AZN) Denali Therapeutics Inc. Common Stock (DNLI) Royalty Pharma plc Class A Ordinary Shares (RPRX) Marblex (MBX) Goldman Sachs (GS) Incyte Corporation (INCY) TG Therapeutics, Inc. (TGTX) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Cidara Therapeutics, Inc. (CDTX) One Cash (ONC) Novartis AG (NVS) GoodRx Holdings, Inc. Class A Common Stock (GDRX) Curate (XCUR) Axsome Therapeutics, Inc (AXSM) Arrowhead Research Corporation (ARWR)

Top Social Posts

Top posts by engagements in the last XX hours

"$LLY cuts prices of Zepbound weight loss drug vials on direct-to-consumer site. Cash-paying patients with a valid prescription can pay $XXX to $XXX per month for Zepbound vials on LillyDirect. $NVO $HIMS"
X Link 2025-12-01T13:15Z 70.5K followers, 11.1K engagements

"$CBIO $185M PIPE. Forbion Fairmount Vestal Point Capital BVF Partners ADAR1 Balyasny Asset Management and Venrock Healthcare Capital"
X Link 2025-12-04T11:37Z 70.5K followers, 11.1K engagements

"$AXGN FDA Approves BLA for AVANCE"
X Link 2025-12-04T01:25Z 70.5K followers, 8866 engagements

"$WVE Further clinical data including six-month follow-up from the XXX mg single-dose cohort and three-month follow-up from XXX mg single-dose cohort expected in Q1"
X Link 2025-12-08T12:34Z 70.5K followers, 3578 engagements

"$BBIO initiated with an Outperform at Bernstein. PT $94"
X Link 2025-12-11T10:59Z 70.5K followers, 3264 engagements

"$RYTM Q3 net product revenue from global sales of IMCIVREE of $51.3M -Preliminary data from Setmelanotide Phase X trial in Prader-Willi syndrome in Q4"
X Link 2025-11-04T12:10Z 70.4K followers, 3520 engagements

"$RYTM FDA requested additional sensitivity analyses of clinical efficacy data from Phase X pivotal trial in acquired hypothalamic obesity. No new data were requested. The additional information has been deemed a major amendment"
X Link 2025-11-07T12:32Z 70.4K followers, 6516 engagements

"$AVDL Board Declares Lundbeck Proposal a Company Superior Proposal. $ALKS"
X Link 2025-11-17T10:53Z 70.5K followers, 9823 engagements

"$ALKS Announces Increased Offer to Acquire $AVDL $22.50/share - consisting of $21/share in cash + $XXXX CVR"
X Link 2025-11-19T11:02Z 70.5K followers, 6164 engagements

"$RYTM initiated with a Buy at Citi. PT $136"
X Link 2025-11-25T11:11Z 70.4K followers, 3918 engagements

"Eisai Completes Rolling sBLA Submission for LEQEMBI IQLIK (lecanemab-irmb) as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease Under Fast Track Status. $BIIB"
X Link 2025-11-25T12:36Z 70.5K followers, 4280 engagements

"$PYXS $350M shelf $150M ATM"
X Link 2025-11-26T14:47Z 70.4K followers, 4917 engagements

"30% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These X Biopharma Stocks $NTRA $INSM $TEVA $XBI"
X Link 2025-11-30T16:06Z 70.4K followers, 16.8K engagements

"$IONS receives FDA Breakthrough Therapy designation for zilganersen for Alexander disease (AxD)"
X Link 2025-12-02T12:04Z 70.4K followers, 3365 engagements

"$AZN Baxdrostat NDA accepted under FDA Priority Review for patients with hard-to-control hypertension. PDUFA anticipated in Q2'26 following use of Priority Review voucher"
X Link 2025-12-02T14:20Z 70.5K followers, 5559 engagements

"$DNLI and $RPRX Announce $275M Royalty Funding Agreement"
X Link 2025-12-04T12:01Z 70.5K followers, 3883 engagements

"$MBX initiated with a Sell at Goldman Sachs. PT $18"
X Link 2025-12-04T12:49Z 70.4K followers, 5724 engagements

"$KYMR Announces Positive Results from BroADen Phase 1b Clinical Trial of KT-621 a First-in-Class Oral STAT6 Degrader in Patients with Moderate to Severe Atopic Dermatitis"
X Link 2025-12-08T12:01Z 70.4K followers, 25.8K engagements

"$INCY PT raised to $XXX at Wells Fargo"
X Link 2025-12-08T12:13Z 70.4K followers, 3036 engagements

"PM movers - $WVE XX% $FULC XX% $KYMR XX $OCUL XX% $DYN XX% $KMDA X% $XBI #biotech"
X Link 2025-12-08T12:54Z 70.4K followers, 11.5K engagements

"$ARTL offering"
X Link 2025-09-29T23:17Z 70.5K followers, 5033 engagements

"$TGTX Q3 EPS $XXXX beats $XXXX Est. Sales $161.7M beat $152M Est 🔥 Raises FY2025 Sales Guidance from $585M to $600M"
X Link 2025-11-03T12:03Z 70.5K followers, 5932 engagements

"$MDGL Presents New Data Demonstrating Rezdiffra Significantly Improved Multiple Noninvasive Imaging Tests and Biomarkers in Patients with Compensated MASH Cirrhosis"
X Link 2025-11-10T13:03Z 70.5K followers, 5146 engagements

"$BHVN $150M offering"
X Link 2025-11-11T21:09Z 70.4K followers, 8078 engagements

"$TARA Announces Positive Interim Results Demonstrating Robust Responses in the Ongoing Phase X STARBORN-1 Trial of TARA-002 in Pediatric Patients with Lymphatic Malformations"
X Link 2025-11-19T13:01Z 70.5K followers, 5496 engagements

"$MDGL PT raised to $XXX at Oppenheimer"
X Link 2025-11-20T11:17Z 70.5K followers, 5649 engagements

"$CDTX Reaches Target Enrollment of Phase X ANCHOR Trial Evaluating CD388 for Prevention of Seasonal Influenza in High-Risk Populations. Interim analysis in Q1"
X Link 2025-11-24T13:01Z 70.5K followers, 3062 engagements

"$ONC FDA Grants Priority Review to Sonrotoclax NDA for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma"
X Link 2025-11-26T11:03Z 70.5K followers, 4146 engagements

"$TARA $75M offering priced at $5.75/share"
X Link 2025-12-05T03:14Z 70.5K followers, 5109 engagements

"$HIMS initiated with an Overweight at Barclays. PT $48"
X Link 2025-12-09T02:05Z 70.5K followers, 4097 engagements

"$NVS collaboration with Relation Therapeutics to discover and advance novel targets for atopic diseases. Relation to receive $55M upfront"
X Link 2025-12-09T10:25Z 70.5K followers, 5134 engagements

"$TERN PT raised to $XX at Barclays"
X Link 2025-12-09T11:01Z 70.5K followers, 3693 engagements

"$TERN $400M offering"
X Link 2025-12-09T11:19Z 70.5K followers, 7158 engagements

"$LLY Jaypirca (pirtobrutinib) significantly improved progression-free survival reducing the risk of progression or death by XX% versus chemoimmunotherapy in patients with treatment-nave CLL/SLL"
X Link 2025-12-09T12:43Z 70.5K followers, 4395 engagements

"$GDRX covg initiated with an Underweight at Barclays. PT $3"
X Link 2025-12-09T12:51Z 70.5K followers, 3536 engagements

"$OCUL AH vol"
X Link 2025-12-06T02:12Z 70.5K followers, 8832 engagements

"$OCUL plans to leverage the 505(b)(2) regulatory pathway for new drug approvals which has the potential to shorten the review timeline for AXPAXLI"
X Link 2025-12-08T12:04Z 70.5K followers, 6162 engagements

"$DYN $350M offering priced at $XXXXX per share"
X Link 2025-12-10T02:49Z 70.5K followers, 3529 engagements

"$XCUR Completes the Last Patient Last Visit in Phase X Study of GPC-100 for Stem Cell Mobilization in Multiple Myeloma Patients Undergoing Autologous Transplant. Topline data Q4"
X Link 2025-08-02T14:26Z 70.5K followers, 3618 engagements

"$ACIU third Alzheimers disease cohort (AD3) in the Phase X ABATE trial of anti-Abeta ACI-24.060 to reach XX months of treatment in December with interim data expected early 2026"
X Link 2025-08-05T11:11Z 70.5K followers, 3611 engagements

"$CORT Submits MAA to the EMA for Relacorilant as a Treatment for Patients with Platinum-Resistant Ovarian Cancer"
X Link 2025-10-14T12:03Z 70.5K followers, 3743 engagements

"$CYBN $175M PIPE Venrock Partners OrbiMed Point72 Deep Track Capital Acorn Bioventures Spruce Street Capital Squadron Capital Adage Capital Boxer Capital ADAR1 Capital Management Stonepine Capital Management Pivotal Bioventure Partners Ally Bridge Group"
X Link 2025-10-28T12:03Z 70.5K followers, 21.8K engagements

"$PDSB to Seek Expedited Approval Pathway for PDS0101 in HPV16-Positive Head and Neck Cancer"
X Link 2025-10-29T12:41Z 70.5K followers, 8028 engagements

"$AXSM total Q3 net product revenue $171M. XX% YoY AUVELITY net product sales of $136.1M. XX% YoY"
X Link 2025-11-03T12:06Z 70.5K followers, 6336 engagements

"$PRQR initiating Phase X study of AX-0810 with initial safety tolerability and PK data from Cohort X expected by EOY and target engagement data from all cohorts in 1H'26 Cash and cash equivalents 107M"
X Link 2025-11-06T12:12Z 70.5K followers, 3718 engagements

"$DAWN to Acquire $MRSN for $25/share cash + CVR"
X Link 2025-11-13T11:01Z 70.5K followers, 22.6K engagements

"$25/share in cash plus up to an aggregate of $30.25/share in cash potentially payable under the CVR for total consideration of up to $55.25/share in cash. $DAWN $MRSN"
X Link 2025-11-13T11:09Z 70.5K followers, 6698 engagements

"$SRPT Progress Update for SRP-1003 its Investigational siRNA treatment for Myotonic Dystrophy Type 1"
X Link 2025-11-24T12:33Z 70.5K followers, 8503 engagements

"Indian Court Rejects $NVO's Injunction Plea Allows Dr. Reddy's to Manufacture and Export Generic Versions of Semaglutide. $RDY"
X Link 2025-12-04T11:46Z 70.5K followers, 5615 engagements

"$MNOV $300M shelf $LUCD $175M shelf $MYNZ $150M shelf $RZLT shelf"
X Link 2025-12-06T04:33Z 70.5K followers, 4272 engagements

"$WVE upgraded to Outperform at RBC. PT raised to $XX from $9"
X Link 2025-12-09T02:41Z 70.5K followers, 4290 engagements

"$SRPT initiated with an Outperform at Wedbush. PT $32"
X Link 2025-12-09T12:05Z 70.5K followers, 4643 engagements

"$LUCD Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection"
X Link 2025-12-09T13:02Z 70.5K followers, 11.6K engagements

"$WVE $350M offering priced at $19/share"
X Link 2025-12-10T02:51Z 70.5K followers, 5694 engagements

"$TERN $650M offering Whoa 16.25M shares at $40/share"
X Link 2025-12-10T04:36Z 70.5K followers, 15K engagements

"#Biotech offerings priced - $TERN $650M at $40/share $GPCR $650M at $65/ADS $KYMR $602M at $86/share $WVE $350M at $19/share $DYN $350M at $18.44/share $VERA $261M at $42.50/share $XXXX Billion💥 $XBI"
X Link 2025-12-10T04:47Z 70.5K followers, 25.2K engagements

"$LLY triple agonist Retatrutide delivered weight loss of up to an average of XXXX lbs along with substantial relief from osteoarthritis pain in first successful Phase X trial. $NVO $VKTX $GPCR"
X Link 2025-12-11T11:53Z 70.5K followers, 6844 engagements

"TD Cowen analyst highlights #biotech stocks driving next wave of innovation. $QURE $XENE $UTHR $XBI"
X Link 2025-10-18T13:52Z 70.5K followers, 4206 engagements

"$NVO Phase X trial with amycretin reports significant weight loss and HbA1c reduction in type X diabetes. Amycretin showed statistically significant weight loss of up to XXXX% at XX weeks. $LLY $VKTX"
X Link 2025-11-25T11:30Z 70.5K followers, 52.3K engagements

"Biotech Stocks Facing FDA Decision In December $AXGN $AGIO $BCRX $MIST $INVA $ALDX $OMER $CYTK $VNDA $CORT $OTLK $XBI"
X Link 2025-11-30T14:10Z 70.5K followers, 12.3K engagements

"$ACIU AC Immune Positive Interim Phase X Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinsons Disease"
X Link 2025-12-11T12:01Z 70.5K followers, 10.8K engagements

"$ACIU resumes 35%"
X Link 2025-12-11T12:32Z 70.5K followers, 6041 engagements

"$RZLT PT raised to $XX at Citizens JMP"
X Link 2025-10-29T10:48Z 70.5K followers, 11.6K engagements

"$PALI PT raised to $X at Maxim"
X Link 2025-11-11T18:51Z 70.5K followers, 16.1K engagements

"$RZLT PT raised to $XX at Jefferies"
X Link 2025-12-06T13:28Z 70.5K followers, 5643 engagements

"$RZLT #FAIL Rezolute Phase X sunRIZE Study Results in Congenital Hyperinsulinism did not meet the primary or key secondary endpoint"
X Link 2025-12-11T12:01Z 70.5K followers, 10.2K engagements

"$RZLT XX% reduction in hypoglycemia events observed at top ersodetug dose (10 mg/kg) compared to XX% improvement in placebo arm"
X Link 2025-12-11T12:02Z 70.5K followers, 15.3K engagements

"$RYTM Announces Preliminary Data from Exploratory Phase X Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome"
X Link 2025-12-11T12:31Z 70.5K followers, 5252 engagements

"$RZLT resumes"
X Link 2025-12-11T12:42Z 70.5K followers, 27.9K engagements

"$RZLT brutal"
X Link 2025-12-11T12:43Z 70.5K followers, 15.9K engagements